
Venzheha Victoriia
@venzhehav
ID: 951393849984856064
11-01-2018 10:02:24
32 Tweet
8 Takipçi
48 Takip Edilen


Pulmonary hypertension 2019: a roadmap for cardiologists. Watch this webinar to be updated on the treatment options & management of PH, when it occurs in #HF or is due to chronic thromboembolic disease bit.ly/2Sdz8ze Free for everyone. Jean-Luc Vachiery 🫀 #Hypertension




Most read articles for 2019 at circinterventions.ahajournals.org➡️ Infarct-related artery in #NSTEMI, Intravascular Lithotripsy for Rx of Calcified CAD (Disrupt CAD II Study) DCB for SFA disease (IN.PACT SFA Trial), Rx in Patients w/CABG & NSTEMI (CABG-ACS Trial) Circulation #AHAJournals






primacy of atrial myopathy as a critical component of HFpEF, rather than AF, as the mediator of systemic thromboembolism in obesity or diabetes. Alfonso Valle Shelley Zieroth Paola Morejón Barragán Giuseppe Galati C. Michael Gibson MD Montserrat Carrillo @DLenihanICOS_MD Gonzalo Perez Dr.Rajiv Sankaranarayanan


Peripartum Cardiomyopathy - important overview in the newest JACC Journals #Cardiotwitter #CardioEd HFAPresident onlinejacc.org/content/75/2/2…


In this #JACC Review Topic, Drs. Felipe Bisbal, Adrian Baranchuk MD FACC FRCPC FCCS FSIAC et al. propose the term "atrial failure" as an independent, clinically relevant entity beyond #Afib and #HeartFailure with a diversity of etiologies, mechanisms, and manifestations. bit.ly/30itSMW


Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In this #JACCCardioOnc Primer, Drs. Adam DeVore, MD, MHS, Michael Felker and Duke Health colleagues present best practices for ATTR-CM management. bit.ly/38ec6Nl


Similar risk of stroke with dabigatran vs rivaroxaban vs apixaban but lower risk of major bleeding with dabigatran and apixaban vs. rivaroxaban: real-world data from Norway bit.ly/2xztPls #EHJPharmacotherapy Stefan Agewall #cardiotwitter






I am often asked which is more dangerous--ascending dilatation or root dilatation. Dr. Kalogerakos, from our Aortic Institute team, has given us a scientific answer: The root is more dangerous. ahajournals.org/doi/10.1161/JA… Mohammad A. Zafar, MD Bulat A. Ziganshin, MD, PhD Yale Surgery Yale Cardiac Surgery
